MedPath

Jenavalve Technology, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™

Not Applicable
Not yet recruiting
Conditions
Aortic Regurgitation
Aortic Valve Insufficiency
Aortic Insufficiency
Interventions
Device: Transcatheter Aortic Valve Replacement (TAVR) using Trilogy THV System
Device: SAVR
First Posted Date
2024-09-23
Last Posted Date
2025-02-20
Lead Sponsor
JenaValve Technology, Inc.
Target Recruit Count
1016
Registration Number
NCT06608823
Locations
🇺🇸

Cedar-Sinai Medical Center, Los Angeles, California, United States

🇺🇸

Cumc/Nyph, New York, New York, United States

The JenaValve ALIGN-AR LVAD Registry

Not Applicable
Not yet recruiting
Conditions
Aortic Regurgitation
Aortic Valve Insufficiency
Aortic Insufficiency
Aortic Valve Disease
Left Ventricular Dysfunction
Interventions
Device: JenaValve Trilogy Heart Valve System
First Posted Date
2024-09-19
Last Posted Date
2024-10-16
Lead Sponsor
JenaValve Technology, Inc.
Target Recruit Count
50
Registration Number
NCT06594705
Locations
🇺🇸

Columbia University Medical Center/New York-Presbyterian Hospital, New York, New York, United States

TAVIS Registry - Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease

Not yet recruiting
Conditions
Constriction, Pathologic
Ventricular Outflow Obstruction
Heart Valve Diseases
Aortic Valve Stenosis
Aortic Valve Regurgitation
Aortic Valve Disease
Aortic Stenosis, Severe
Aortic Valve Stenosis With Insufficiency
Cardiovascular Diseases in Old Age
Interventions
Device: Transcatheter Aortic Valve Implantation (TAVI)
First Posted Date
2022-09-10
Last Posted Date
2023-01-11
Lead Sponsor
JenaValve Technology, Inc.
Target Recruit Count
600
Registration Number
NCT05536310
Locations
🇩🇪

University Hospital of Cologne Heart Center, Köln, Germany

🇩🇪

University Hospital Mainz, Mainz, Germany

🇩🇪

Herz-und Diabeteszentrum NRW Ruhr-Universität Bochum Bad Oeynhausen, Bad Oeynhausen, Germany

The JenaValve ALIGN-AR Pivotal Trial

Not Applicable
Active, not recruiting
Conditions
Aortic Valve Insufficiency
Aortic Insufficiency
Aortic Valve Disease
Aortic Regurgitation
Interventions
Device: JenaValve Trilogy Heart Valve System
First Posted Date
2020-06-04
Last Posted Date
2022-09-13
Lead Sponsor
JenaValve Technology, Inc.
Target Recruit Count
180
Registration Number
NCT04415047
Locations
🇺🇸

Emory University Hospital, Atlanta, Georgia, United States

🇺🇸

Ohio Health Research Institute, Columbus, Ohio, United States

🇺🇸

Morton Plant/ BayCare Health, Clearwater, Florida, United States

and more 27 locations

First in Man Study of the JenaValve TAVI Plus System Transfemoral

Not Applicable
Terminated
Conditions
Heart Diseases
Heart Valve Diseases
Aortic Valve Stenosis
Cardiovascular Diseases
Interventions
Device: JenaValve Pericardial TAVR System
First Posted Date
2016-06-30
Last Posted Date
2020-05-21
Lead Sponsor
JenaValve Technology, Inc.
Target Recruit Count
7
Registration Number
NCT02818959
Locations
🇩🇪

University of Hamburg Medical Center, Hamburg, Germany

🇩🇪

University of Koln Medical Center, Koln, Germany

JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study

Not Applicable
Active, not recruiting
Conditions
Heart Valve Diseases
Ventricular Outflow Obstruction
Aortic Valve Stenosis
Heart Diseases
Cardiovascular Diseases
Interventions
Device: JenaValve Pericardial TAVR System
First Posted Date
2016-04-11
Last Posted Date
2022-11-22
Lead Sponsor
JenaValve Technology, Inc.
Target Recruit Count
68
Registration Number
NCT02732691
Locations
🇺🇸

Columbia University Medical Center, New York, New York, United States

🇩🇪

Deutsches Herzzentrum Berlin, Berlin, Germany

🇺🇸

MedStar Washington Hospital Center, Washington, District of Columbia, United States

and more 10 locations

THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

Not Applicable
Active, not recruiting
Conditions
Aortic Regurgitation
Interventions
Device: JenaValve Pericardial TAVR System
First Posted Date
2016-04-11
Last Posted Date
2022-11-18
Lead Sponsor
JenaValve Technology, Inc.
Target Recruit Count
100
Registration Number
NCT02732704
Locations
🇺🇸

Cedars Sinai Medical Center, Los Angeles, California, United States

🇳🇱

St. Antonius Hospital, Nieuwegein, Netherlands

🇳🇱

Erasmus University Medical Center, Rotterdam, Netherlands

and more 16 locations

JUPITER Study: Transapical Aortic Valve Implantation for Aortic Regurgitation

Completed
Conditions
Aortic Stenosis
Aortic Regurgitation
Aortic Insufficiency
Interventions
Device: Transcatheter aortic valve replacement
First Posted Date
2012-05-15
Last Posted Date
2020-11-24
Lead Sponsor
JenaValve Technology, Inc.
Target Recruit Count
210
Registration Number
NCT01598844
Locations
🇨🇭

Universitätsspital Basel, Basel, Switzerland

🇩🇪

Herz- und Diabeteszentrum NRW, Bad Oeynhausen, Germany

🇩🇪

Herzzentrum Dresden, Universitätsklinik an der Technischen Universität Dresden, Dresden, Germany

and more 12 locations
© Copyright 2025. All Rights Reserved by MedPath